The COVID-19 pandemic and the subsequent rush to develop life-saving vaccines have posed enormous challenges for practitioners in all areas of the life sciences and health care industries, including those whose area of focus...more
In This Issue:
- The New “Clear Error” Standard of Review in Patent Infringement Mediation
- Trademark Trial Appeal Board Decisions Now Have Preclusive Effect
- Engaging Panelists for Neutral Analysis Provides...more
5/20/2015
/ Clear Error Standard ,
Intellectual Property Litigation ,
Mediation ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Standard of Review ,
Teva Pharmaceuticals ,
Trademark Litigation ,
Trademark Trial and Appeal Board ,
Trademarks